Literature DB >> 9575217

Jak2-Stat5 interactions analyzed in yeast.

F Barahmand-Pour1, A Meinke, B Groner, T Decker.   

Abstract

Many cytokine receptors employ Janus protein tyrosine kinases (Jaks) and signal transducers and activators of transcription (Stats) for nuclear signaling. Here, we have established yeast strains in which an autoactivated Jak2 kinase induces tyrosine phosphorylation, dimerization, nuclear translocation, and DNA binding of a concomitantly expressed Stat5 protein. Transcriptional activity of Stat5 on a stably integrated, Stat-dependent reporter gene required the C-terminal fusion of the VP16 transactivation domain. In such yeast strains, the interaction between Jak2 and Stat5 was analyzed without interference by other mammalian proteins involved in regulating Jak-Stat signaling, and mutant versions of both proteins were analyzed for their ability to productively interact. Complexes between Jak2 and Stat5 were found to be stable under stringent co-immunoprecipitation conditions. Deletion of the Jak homology regions 2-7 (JH2-JH7) of Jak2, leaving only the kinase domain (JH1) intact, reduced the ability of the kinase to phosphorylate Stat5, whereas deletion of the JH2 domain caused an increased enzymatic activity. A site-directed R618K mutation in the Stat5 SH2 domain abolished the phosphorylation by Jak2, while deletion of the C terminus led to Stat5 hyperphosphorylation. A single phosphotyrosine-SH2 domain interaction was sufficient for the dimerization of Stat5, but such dimers bound to DNA very inefficiently. Together, our data show that yeast cells are appropriate tools for studying Jak-Stat or Stat-Stat interactions. Our mutational analysis suggests that the Stat5 SH2 domain is essential for the interaction with Jak2 and that the kinase domain of Jak2 is sufficient for Jak2-Stat5 interaction. Therefore, the Jak kinase domain may be all that is needed to cause Stat phosphorylation in situations where receptor docking is dispensable.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9575217     DOI: 10.1074/jbc.273.20.12567

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Regulation of the Jak2 tyrosine kinase by its pseudokinase domain.

Authors:  P Saharinen; K Takaluoma; O Silvennoinen
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.

Authors:  Sara M N Onnebo; Parisa Rasighaemi; Janani Kumar; Clifford Liongue; Alister C Ward
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

3.  Distinct roles of the NH2- and COOH-terminal domains of the protein inhibitor of activated signal transducer and activator of transcription (STAT) 1 (PIAS1) in cytokine-induced PIAS1-Stat1 interaction.

Authors:  J Liao; Y Fu; K Shuai
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

4.  Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression.

Authors:  P Kovarik; M Mangold; K Ramsauer; H Heidari; R Steinborn; A Zotter; D E Levy; M Müller; T Decker
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

Review 5.  The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.

Authors:  Bin Cai; Jian-ping Cai; Yu-long Luo; Cheng Chen; Sen Zhang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 6.  The JAK/STAT signaling pathway: from bench to clinic.

Authors:  Xiaoyi Hu; Jing Li; Maorong Fu; Xia Zhao; Wei Wang
Journal:  Signal Transduct Target Ther       Date:  2021-11-26

7.  Hematopoietic cell survival signals are elicited through non-tyrosine-containing sequences in the membrane-proximal region of the erythropoietin receptor (EPOR) by a Stat5-dependent pathway.

Authors:  Donghoon Yoon; Stephanie S Watowich
Journal:  Exp Hematol       Date:  2003-12       Impact factor: 3.084

8.  Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma.

Authors:  M Vaysberg; S L Lambert; S M Krams; O M Martinez
Journal:  Am J Transplant       Date:  2009-07-28       Impact factor: 8.086

9.  Three distinct patterns of histone H3Y41 phosphorylation mark active genes.

Authors:  Mark A Dawson; Samuel D Foster; Andrew J Bannister; Samuel C Robson; Rebecca Hannah; Xiaonan Wang; Blerta Xhemalce; Andrew D Wood; Anthony R Green; Berthold Göttgens; Tony Kouzarides
Journal:  Cell Rep       Date:  2012-09-20       Impact factor: 9.423

10.  Voting-based cancer module identification by combining topological and data-driven properties.

Authors:  A K M Azad; Hyunju Lee
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.